Global Healthcare Exchange (GHX) and the Association of Healthcare Value Analysis Professionals (AHVAP) have released the results of a comprehensive survey analyzing healthcare value analysis (HVA). The findings show that HVA is...
Read MoreOn September 17, 2024, the FDA approved ribociclib (Kisqali, Novartis Pharmaceuticals Corporation) in combination with an aromatase inhibitor to treat adults with hormone receptor-positive, HER2-negative early breast cancer at...
Read MoreSOMAÍ Pharmaceuticals has partnered with Georgelle Pharmaceutical to introduce the most extensive range of cannabis-based medicines to Ireland. The partnership aims to provide Irish patients with high-quality cannabis-based...
Read More
The FDA has approved AstraZeneca’s Fasenra (benralizumab) to treat adult patients with...
Read MoreSerpin Pharma has collaborated with Uniklinikum Erlangen to conduct a Phase IIa clinical trial evaluating SP163M, a new therapeutic designed to prevent acute kidney injury (AKI) in patients with stage 2-3 chronic kidney disease...
Read More